Oxford Nanopore Technologies Plc.
Company Snapshot
Company Overview
Founded in 2005 as a spinoff from the University of Oxford, Oxford Nanopore Technologies Ltd. Is developing a real-time, label-free, single-molecule DNA sequencing technology. GridIon, Oxford’s nanopore platform, can also be applied to protein and other single-molecule analyses and liquid biopsies.
Oxford Nanopore’s objective is to make the ability to analyze DNA, in real time available to every biologist. The company is focused on developing small, portable, and less expensive sequencers. The business model is to offer the sequencing device for free and charge for consumables.
Oxford Nanopore’s leading product platform includes the MinIon (portable sequencer), PromethIon (high-throughput sequencer), GridION, and VolTrax (automated sample preparation device).
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Oxford Nanopore Technologies Plc. In Reports
Company's Business Segments
- Sale of Goods : This segment includes selling goods like nanopore sequencing devices, consumables, related products to their customers.
- Rendering of Services : This segment includes providing support, training, and technical assistance to customers using their sequencing platforms.
- Lease Income : This segment generates revenue from leasing or renting out their sequencing instruments to customers.
Applications/End User Industries
- Infectious Diseases
- Epigenetics
- Single-Nucleotide Polymorphism
- Microbiome
- Fusion Transcripts
- Human Genetics
- Population Genomics
- Structural Variation
- Transcriptome
- In Vitro Diagnostics
- Healthcare
- Life Sciences
